SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energys strong Q3 results and raised full-year outlook were overshadowed by a sharp share-price selloff, with traders debating negative cash flow from investment and working-capital needs alongside a stretched valuation. Bulls point to continued demand for onsite power from data centers, while others see the move as part of a broader pullback in AI-related stocks.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna shares sold off sharply after an embargo breach brought forward Phase 3 data on its melanoma vaccine with Mercks Keytruda. Traders debate whether the positive reduction in recurrence risk still fell short of elevated expectations and warrants a sell-the-news repricing, or whether the drop overstates the datas significance.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. It operates through the Hard Disk Drives (HDD) segment. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Western Digitals strong quarterly results and raised outlook are being met with a sharp selloff, prompting traders to question why positive fundamentals are not supporting the shares. The debate centers on broader AI and storage-sector de-risking and fears of peak-cycle margins versus confidence that data-center storage demand remains strong.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

A sharp semiconductor and tech selloff, alongside oil and Iran-related market concerns and renewed worries about financing AI infrastructure, has hammered SOXL; its 3x leverage magnifies the sectors decline. Traders are split between calling the drop an oversold buying opportunity and expecting further losses as AI spending and semiconductor valuations are reassessed.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apples resilience near record highs despite weakness in broader tech is drawing attention; traders cite safe-haven flows and iPhone Duo preorder and backorder chatter as possible support. Skeptics question the valuation and Apples innovation, AI progress, and demand outlook, particularly ahead of earnings.

Forgent Power Solutions, Inc. is a holding company, which engages in the design and manufacture of electrical distribution equipment used in data centers, power grid, and energy-intensive industrial facilities. It also offers powertrain solutions and standard and custom products. The company was founded on July 21, 2025 and is headquartered in Dayton, MN.

Forgent Power Solutions Inc. - Ordinary Shares - Class A

Forgent Power Solutions Inc.

Forgents CFO departure triggered a steep selloff and speculation about possible financial problems, though the company said the exit was unrelated to any disagreement and announced that preliminary quarterly revenue and adjusted EBITDA would exceed prior guidance. Traders are divided between calling the drop an overreaction and saying the leadership change and communication have shaken confidence.

AT&T, Inc. is a holding company, which engages in the provision of telecommunications and technology services. It operates through the Communications and Latin America segments. The Communications segment offers wireless, wireline telecom, and broadband services to businesses and consumers located in the US and businesses globally. The Latin America segment provides wireless services and equipment in Mexico. The company was founded in 1983 and is headquartered in Dallas, TX.

AT&T, Inc.

AT&T Inc

AT&Ts earnings beat and higher full-year outlook were followed by a sharp selloff, as traders focused on slightly weaker-than-expected postpaid phone additions and competition fears around SpaceXs planned mobile service. The shares are rebounding, with many traders viewing the drop as an overreaction and buying the dip, while others remain concerned about growth and the longer-term competitive threat.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

Alphabet shares are under pressure ahead of earnings, with traders focused on whether Search can withstand AI competition and whether heavy AI spending will generate adequate returns; Cloud growth and earnings guidance are also key watchpoints. The debate is polarized: some expect more downside if results or capex outlook disappoint, while others view the selloff as a buying opportunity given Alphabets cash generation and AI position.

Newmont Corp. engages in the exploration and acquisition of gold properties, containing copper, silver, lead, zinc or other metals. It operates through the following geographical segments: Papua New Guinea, Australia, Ghana, Suriname, Argentina, Peru, Mexico, Canada, and U.S. The company was founded by William Boyce Thompson on May 2, 1921 and is headquartered in Denver, CO.

Newmont Corp

Newmonts stronger-than-expected Q3 results and improved cost outlook are drawing attention, but shares have weakened despite the beat. Traders are weighing strong cash generation against a Freedom Broker downgrade that cited rising Australian costs and execution risks at Lihir and Cadia.

Deckers Outdoor Corp. engages in the business of designing, marketing, and distributing footwear, apparel, and accessories developed for both everyday casual lifestyle use and high performance activities. It operates through the following segments: UGG Brand, HOKA Brand, Teva Brand, Sanuk Brand, Other Brands, and Direct-to-Consumer. The UGG Brand segment offers a line of premium footwear, apparel, and accessories. The HOKA Brand segment sells footwear and apparel that offers enhanced cushioning and inherent stability with minimal weight, originally designed for ultra-runners. The Teva Brand segment focuses on the sport sandal and modern outdoor lifestyle category, such as sandals, shoes, and boots. The Sanuk Brand segment originated in Southern California surf culture and has emerged into a lifestyle brand with a presence in the relaxed casual shoe and sandal categories. The Other Brands segment includes the Koolaburra by UGG brand. The Direct-to-Consumer segment consists of retail stores and e-commerce websites. The company was founded by Douglas B. Otto in 1973 and is headquartered in Goleta, CA.

Deckers Outdoor Corp.

Deckers latest results sparked a selloff as traders focused on a lowered full-year sales outlook and slower HOKA and UGG growth, despite an earnings beat and higher EPS guidance. The community is split between seeing the reaction as an overreaction given strong margins and buybacks, and worrying that softer demand and footwear-sector weakness could weigh on growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

DexCom's G7 Shows Strong Results in Type 2 Diabetes CONNECT Study

DXCM's G7 delivers strong results in the CONNECT study, improving A1C levels and glucose control in non-insulin users with Type 2 diabetes, supporting CGM adoption.

Vaso Stock Surges 149% in a Year: What's Behind the Rally?

VASO is gaining from higher equipment deliveries, growing deferred commissions and a sharper healthcare focus, though partner dependence and margin pressures persist.

Landmark Dexcom CONNECT Study Published in The New England Journal of Medicine, Redefining the Standard of Care for People with Type 2 Diabetes Not on Insulin

DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today announced that results from the landmark CONNECT randomized controlled trial have been published in The New England Journal of Medicine (NEJM), providing rigorous evidence of the significant benefits of continuous glucose...

Here's Why You Should Retain DexCom Stock in Your Portfolio for Now

DexCom's strong margins, G7 15-day rollout and promising pipeline support its growth outlook, but factory ramp-up costs, forex and input-price pressures pose risks.

Dexcom Schedules Third Quarter 2026 Earnings Release and Conference Call for October 29, 2026 at 4:30 p.m. Eastern Time

DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2026 financial results after market close on Thursday, October 29, 2026. Management will hold a conference call to review the company's third quarter 2026 performance starting at 4:30 p.m. (Eastern Time) on the...

Dexcom U Enters Season 5 With a Record Roster and Evidence That Diabetes Stigma Among Young Athletes Is Fading

DEXCOM, INC. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today the launch of the fifth season of Dexcom U, the companys one-of-a-kind NIL (Name, Image and Likeness) program exclusively for college athletes with diabetes.This press release features multimedia. View the full...

DXCM Report Highlights CGM Growth Opportunity in Type 2 Diabetes Care

Dexcom sees room to expand CGM adoption as low awareness, reimbursement hurdles and rising GLP-1 use create new opportunities in Type 2 diabetes.

Here's Why DexCom (DXCM) is a Strong Growth Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Dexcom Publishes New Report During EASD 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care

DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today released its Dexcom State of Type 2 Report: Global Access and Attitudes to Diabetes Technology in advance of the 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept...

Dexcom Promotes Jereme Sylvain to Chief Operating Officer

DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today announced the promotion of Jereme Sylvain to the role of Chief Operating Officer (COO) in addition to his duties as Chief Financial Officer. In this expanded role, Mr. Sylvain will assume oversight of Dexcoms global...

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.

Dexcom Inc

Dexcom Stock Plunges 13% After-Hours As Q3 Margin Pressures Eclipse Record Profit — Retail Sees ‘Buy The Dip’ Setup

Equity

Bullish Sentiment

<ul class="summary-bullets"><li>Investors focused on Dexcom’s lower gross margin of 61.3%, down about 170 basis points year-over-year, despite record revenue and earnings.</li><li>The company said elevated scrap and freight costs would continue to pressure margins in the near term, even as efficiency improvements are underway.</li><li>Some retail traders viewed the decline as a buying opportunity, calling the after-hours drop “uncalled for.”&nbsp;</li></ul>Dexcom shares slid 13% in after-hours trading on Thursday, as investors looked past a record third-quarter (Q3) profit and focused instead on rising costs and a cautious outlook for next year.The glucose monitoring company reported $1.21 billion in revenue for Q3, up 22% year over year, driven by strong demand across the U.S. and international markets. Net income jumped to $242.5 million, or $0.61 per share, its highest ever.Dexcom also raised its full-year revenue forecast to $4.63-$4.65 billion, representing around 15% growth. However, the company’s upbeat sales&nbsp;weren’t enough to offset concerns about profitability, as it said gross margins will remain near 61%, down about 170 basis points year over year.<h2 class="st-heading-2">Margin Pressure And Outlook</h2>The company acknowledged that elevated scrap rates and freight costs continued to eat into profits. Management said the hit was “roughly half and half” between manufacturing waste and shipping expenses, though both are expected to ease gradually in the coming quarters.Looking ahead, Dexcom projected double-digit revenue growth in 2026, but slightly below Wall Street’s expectations. The forecast does not yet include potential benefits from broader insurance coverage for type 2 diabetes patients, which the company said could provide upside later on.Dexcom added that its new 15-day G7 sensor, currently rolling out to users, will have a limited impact this year but should meaningfully boost margins and growth in 2026 once it gains wider reimbursement.<h2 class="st-heading-2">Growth Drivers Remain Intact</h2>Despite the market reaction, Dexcom’s underlying growth story remains strong. The company continues to expand its reach in the type 2 diabetes market, now covering nearly 6 million non-insulin patients in the U.S.International revenue grew 22%, led by strong momentum in France and Canada following new reimbursement coverage. Its consumer-focused continuous glucose monitor, Stelo, topped $100 million in sales within its first year, with plans to launch in more markets in 2026. Dexcom ended the quarter with over $3.3 billion in cash.<h2 class="st-heading-2">Stocktwits Traders Stay Bullish Despite Selloff</h2>On Stocktwits, retail sentiment for Dexcom was ‘extremely bullish’ amid a 921% surge in 24-hour message volume.<figure class="image"><img style="aspect-ratio:959/126;" src="https://news.stocktwits-cdn.com/dxcm_ss_jpg_7ecd09626d.webp" alt="dxcm ss.jpg" width="959" height="126"><figcaption>DXCM sentiment and message volume as of October 30 | Source: Stocktwits</figcaption></figure>One user said the market reaction reflected disappointment that the company’s longtime executive, now CEO, had signaled that Wall Street’s expectations for 2026 growth were too high, while also acknowledging a slowdown in new patient starts.<stembedurl>https://stocktwits.com/freddycan/message/634416837</stembedurl>Another user said they hoped analysts would issue more bullish reports and raise price targets, describing the selloff as “uncalled for.”<stembedurl>https://stocktwits.com/longshortequities/message/634409824</stembedurl>A third user took the opposite stance, calling the pullback a buying opportunity.<stembedurl>https://stocktwits.com/Okadarlan/message/634408938</stembedurl><a href="https://stocktwits.com/symbol/DXCM">Dexcom’s stock</a> has declined 12% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the DexCom logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Investors focused on Dexcom’s lower gross margin of 61.3%, down about 170 basis points year-over-year, despite record revenue and earnings.

Very bullish

Cautiously bullish

Cautiously bearish

Very bearish

Stocktwits sentiment on $SPY just hit its lowest level of the year. How are you feeling about the market right now?

Stocktwits

 just hit its lowest level of the year. How are you feeling about the market right now?

Stocktwits Polls

$DXCM Hold your nose and buy!  Filled one order, another one waiting.  Best of luck to all longs./

$DXCM update: as of Oct 15, Dexcom still had issued no breach notice and ShinyHunters posted no sample files, so the eight suits plead the alleged theft on information and belief. Nothing to claim. Open Class Actions.

Clam Clamwell

$DXCM (Dexcom) shares fell 1.1% to close at $87.93 as rising Treasury yields and stronger-than-expected economic data pressured healthcare and tech names heading into Thursday's open.

Quassar Capital

Anvesti closed a long position 
$DXCM 🔴 -6.36% 
$82.80 → $77.53 
Model: ml_model_v2 · Score: 81.4 
Reason: Stop Loss · 55 days

AnvestI

$DXCM: the three public complaints do not agree on what was taken. Two allege names, birth dates, licenses and medical records, a third points to glucose readings and support records. Dexcom has confirmed none of it. Open Class Actions.

$DXCM Nice push.  Keep bringing it!  I want to see this move past $82.  Lots of time left in today's trading.  Congrats to those who held their nose this morning and bought low $80's.  I hate to say it, but I told you so!

$DXCM Trying to pin this under $82.  Insti's will be buying today.  The drop is unwarranted on garbage news./

$DXCM: eight Dexcom breach suits sit with six judges in San Diego, not yet consolidated. On Oct 14 one case moved to the first judge under the low-number rule. Breach still unconfirmed, nothing to claim. Open Class Actions.

$DXCM why do people trade at this level while it is mooning based on the data. beats me😂

YoBiDing

$DXCM: Published CONNECT trial data showed Dexcom's G7 cut A1C by 1.6% and added five daily hours in the target range.

Briefing.com

$DXCM 
There’s no reason this should be under $90, I mean really, even seeking Alpha has a strong buy so wtf 🤦🏼‍♀️￼

Feed

News

Sentiment

Earnings

Fundamentals

Info

DXCM Dexcom Inc

Fundamentals

Latest DXCM News